论文部分内容阅读
多发性骨髓瘤(multiple myeloma,MM)属于造血系统恶性肿瘤,是浆细胞恶性增生产生M蛋白所致,多发生于50~70岁的老年人,随着老龄化的到来,其发病率呈逐年上升趋势。MM患者多数因骨痛,肾损害及贫血就诊,是肿瘤相关慢性病贫血的代表性疾病。我科近期收治1例MM合并继发性红细胞增多症患者,现报告如下,并进行相关文献复习,以提高临床医生对此类少见合并症的认识。
Multiple myeloma (MM) is a malignant tumor of hematopoietic system. It is caused by the M protein of malignant proliferation of plasma cells. It occurs mostly in the elderly aged 50 to 70 years old. With the onset of aging, the incidence rate is year by year Upward trend. Most patients with MM due to bone pain, kidney damage and anemia treatment, is a tumor-related chronic diseases anemia, a representative disease. We recently admitted a case of MM combined with secondary polycythemia patients, are reported as follows, and the relevant literature review, in order to improve clinicians awareness of such rare complications.